Jaguar Health (JAGX) Retained Earnings (2014 - 2026)
Jaguar Health's (JAGX) quarterly Retained Earnings came in at -$391.1 million in Q1 2026, down 55771.43% year-on-year from N/an in Q1 2025, and down 46850.78% on a QoQ basis from -$833000.0 in Q4 2025.
Jaguar Health (JAGX) Retained Earnings (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Retained Earnings data on file, last reported at -$391.1 million in Q1 2026.
- On a quarterly basis, Retained Earnings fell 55771.43% year-over-year to -$391.1 million in Q1 2026; TTM through Mar 2026 was -$391.1 million, a 55771.43% decrease from a year earlier, with the FY2025 full-year figure at -$833000.0, up 99.76% from the prior year.
- Retained Earnings for Q1 2026 stood at -$391.1 million, down from -$833000.0 in the prior quarter.
- Over the last five years, Retained Earnings for JAGX reached as high as -$542000.0 in Q2 2024 and fell as low as -$391.1 million in Q1 2026.
- Historically, Retained Earnings has averaged -$197.2 million across 5 years, with a median of -$259.4 million in 2022.
- On a YoY basis, Retained Earnings climbed as much as 99.78% in 2025 and fell as far as 67677.31% in 2025.
- Year by year, Retained Earnings stood at -$266.9 million in 2022, then surged by 99.76% to -$652000.0 in 2023, then sank by 53041.41% to -$346.5 million in 2024, then surged by 99.76% to -$833000.0 in 2025, then plunged by 46850.78% to -$391.1 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$391.1 million in Q1 2026, -$833000.0 in Q4 2025, and -$839000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,792.52 Bn | 1,792.46 Bn | - | -27.27 Mn |
| 2 | Akari Therapeutics | 999.95 Bn | 999.95 Bn | - | -279.01 Mn |
| 3 | BeOne Medicines | 475.97 Bn | 471.17 Bn | 1.35 Bn | 12.91 Bn |
| 4 | Vertex Pharmaceuticals | 124.91 Bn | 117.66 Bn | 2.59 Bn | 14.59 Bn |
| 5 | Regeneron Pharmaceuticals | 72.31 Bn | 63.56 Bn | 3.31 Bn | 11.90 Mn |
| 6 | Belite Bio | 62.01 Bn | 62.01 Bn | - | - |
| 7 | Argenx Se | 54.23 Bn | 49.04 Bn | 1.41 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.31 Bn | 35.30 Bn | 959.66 Mn | -24.89 Mn |
| 9 | Revolution Medicines | 36.16 Bn | 36.16 Bn | - | -622,000.00 |
| 10 | Jaguar Health | 497,735.41 | -9.57 Mn | 19.11 Mn | -391.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -391.10 Mn |
| Dec 31, 2025 | -833,000.00 |
| Sep 30, 2025 | -839,000.00 |
| Jun 30, 2025 | -367.35 Mn |
| Mar 31, 2025 | -700,000.00 |
| Dec 31, 2024 | -346.48 Mn |
| Sep 30, 2024 | -336.60 Mn |
| Jun 30, 2024 | -542,000.00 |
| Mar 31, 2024 | -317.22 Mn |
| Dec 31, 2023 | -652,000.00 |
| Sep 30, 2023 | -299.10 Mn |
| Jun 30, 2023 | -723,000.00 |
| Mar 31, 2023 | -279.20 Mn |
| Dec 31, 2022 | -266.95 Mn |
| Sep 30, 2022 | -259.40 Mn |
| Jun 30, 2022 | -246.85 Mn |
| Mar 31, 2022 | -237.48 Mn |
| Dec 31, 2021 | -219.49 Mn |
| Sep 30, 2021 | -205.18 Mn |
| Jun 30, 2021 | -192.99 Mn |